Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase III high‐risk B acute lymphoblastic leukemia trial AALL0232

Publisher: John Wiley & Sons Inc

E-ISSN: 2045-7634|7|1|3-12

ISSN: 2045-7634

Source: Cancer Medicine, Vol.7, Iss.1, 2018-01, pp. : 3-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content